Research laboratories at the Perkins are organised into the following programs and centres.
Perkins researchers have made major discoveries in the field of cancer including uncovering the SLIRP gene which controls hormone production in breast and prostate cancers, the tumour suppressor gene HLS5 and a process for normalising blood vessels in tumours to allow more effective absorption of cancer-combating drugs.
The Cardiovascular Science and Diabetes Program at the Perkins is focussed on translational research to improve health outcomes. The research teams investigate diseases ranging from heart disease, diabetes, kidney disease and cancer. The program also encompasses the biomedical engineering teams that develop new medical devices.
All donations of $2 and over are tax deductible in Australia.
Perkins is registered with the Australian Taxation Office as a Deductible Gift Recipient (DGR): Charitable Fundraising Authority No DGR CC20761
The Harry Perkins Institute of Medical Research recognises Australia’s first healers and scientists, the Aboriginal and Torres Strait Islander peoples. We acknowledge the Whadjuk people of the Noongar nation, the Traditional Custodians of the lands where we live and work, and pay respects to their elders past and present.
